85042-0

LOINC 2.82

Staphylococcus aureus glycopeptide resistant identified [Type] in Isolate

SA glyco resist Islt

Definition

  • This term is used to report the presence of Staph aureus strains with intermediate or heterogeneous glycopeptide resistance, called GISA and hGISA respectively. One method for differentiating GISA from hGISA is based on comparison of inhibitory concentration results for vancomycin plus teicoplanin [LOINC: 85045-3] with the result for vancomycin alone [LOINC: 7059-9]. This term was created for, but is not limited in use to, bioMerieux's ETEST GRD assay, which, when used together with a vancomycin susceptibility gradient strip, can differentiate between GISA and hGISA.

Component

  • Staphylococcus aureus.glycopeptide resistant identified

Specimen / system

  • Isolate

Class

  • MICRO

Property

  • Type

Scale

  • Nom

Related names

  • ID; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; o71; Point in time; Random; S aureus; SA glyco resist; Staph; Typ

Index terms

  • ID
  • Infectious Disease
  • InfectiousDisease
  • Islt
  • Isol
  • Isolated
  • Microbiology
  • Nominal
  • o71
  • Point in time
  • Random
  • S aureus
  • SA glyco resist
  • Staph
  • Staphylococcus aureus.glycopeptide resistant identified
  • Typ